Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 2950-2956

  Goade, Diane E ^a,c   Bell, Richard ^a,d   Yamada, Takashi ^a,b,e   Mertz, Gregory J ^a   Jenison, Steven ^a,b,c,f  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

^f NEW MEXICO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0029927636     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.2950-2956.1996     Document Type: Article

References (59)

1. Ashley, R. 1993. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med. 69:174-183.
2. Ashley, R., J. Bendetti, and L. Corey. 1985. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J. Med. Virol 17:153-166.
3. Ashley, R., and L. Corey. 1984. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus J. Clin Invest. 73:681-688.
4. Ashley, R., and J. Militoni. 1987. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J. Virol. Methods 18:159-168.
5. Ashley, R., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol 26:662-667.
6. Baghian, A., L. Huang, S. Newman, S. Jayachandra, and K. G. Kousoulas. 1993. Truncation of the carboxy-termmal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb 1511-7 causes extensive cell fusion. J. Virol. 67:2396-2401.
7. Becker, Y. 1992. Computer prediction of antigenic and topogernic domains in HSV-1 and HSV-2 glycoprotein B (gB). Virus Genes 6:131-141.
8. Bernstein, D., Y. Bryson, and M. Covett. 1985 Antibody response to type-common and type-unique epitopes of herpes simplex virus pohpeptides. J. Med. Virol. 15:251-263.
9. Bernstein, D. I., L. M. Frenkel, Y. J. Bryson, and M. G. Myers. 1990. Antibody response to herpes simplex virus glycoproteins gB and gD. J. Med. Virol. 30:45-49.
10. Blacklaws, B. A., S. Krishna, A. C. Minson, and A. A. Nash. 1990. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727-736.
11. Burke, R. L. 1991. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Rev. Infect. Dis. 13: S906-S911.
12. Burke, R. L. 1992. Contemporary approach to vaccination against herpes simplex virus Curr. Top. Microbiol. Immunol. 179:137-158.
13. Bzik, D. J., C. DebRoy, B. A. Fox, N. E. Pederson, and S. Person. 1986. The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1. Virology 155:322-333.
14. Bzik, D. J., B. A. Fox, N. A. DeLuca, and S. Person. 1984. Nucleotide sequence of a region of herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology 137:185-190.
15. Cai, W., S. Person, C. DebRoy, and B. Gu. 1988. Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. J. Mol. Biol. 201:575-588.
16. Cai, W., S. Person, S. Warner, J. Zhou, and N. A. DeLuca. 1987. Linker insertion nonsense and restriction-sue deletion mutations of the gB glycoprotein of herpes simplex virus type 1 J. Virol. 61:714-721.
17. Cantlin, E. M., R. Eberle, J. L. Baldick, B. Moss, D. E. Willey, A. L. Notkins, and H. Openshaw. 1987. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA 84:5908-5912.
18. Chapsal, J. M., and L. Pereira. 1988. Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B. Virology 164:427-434
19. Corey, L. 1991. Clinical studies with herpes simplex virus type 2 Curtis strain vaccine. Rev. Infect. Dis. 13:S904-S905.
20. Eberle, R., and R. J. Courtney. 1981. Assay of type-specific and type-common antibodies to herpes simplex virus type 1 and 2 in human sera. Infect. Immun. 31:1062-1070.
21. Eberle, R., and R. J. Courtney. 1989 Topological distribution of virus-specific and cross-reactive antigenic determinants on the gB glycoprotein of herpes simplex viruses. J. Med. Virol. 27:309-316
22. Gage, P. J., M. Levine, and J. C. Glorioso. 1993 Syncylium-inducing mutations localize 10 two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 67:2191-2201.
23. Gilman, S. C., J. J. Docherty, and W. E. Rawls. 1981. Antibody responses in humans to individual proteins of herpes simplex viruses. Infect. Immun. 34:880-887.
24. Goade, D. E., R. Bell, G. J. Mertz, R. Burke, A. G. M. Langenberg, and S. Jenison. 1995. Development of HSV-2 type-specific antibodies to glycoprotein B In HSV-2 seronegative individuals following immunization with a recombinant gB2/gD2/adjuvant vaccine. Antivir. Res. 26:A342.
25. Goodman, J. L., and J. P. Engel. 1991. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B. J. Virol. 65:1770-1778.
26. Henikoff, S. 1984. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 28:351-359.
27. Highlander, S. L., W. Cai. S. Person, M. Levine, and J. C. Glorioso. 1988. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J. Virol. 62:1881-1888.
28. Highlander, S. L., D. J. Dorney, P. J. Gage, T. C. Holland, W. Cai, S. Person, M. Levine, and J. C. Glorioso. 1989. Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration. J. Virol 63:730-738.
29. Jenison, S. A_ J. M. Firzlaff, A. Langenberg, and D. A. Galloway. 1988. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J. Virol. 62:2115-2123.
30. Jenison, S., T. Yamada, C. Morris, B. Anderson, N. Torrez-Martinez, N. Keller, and B. Hjelle. 1994. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J. Virol 68:3000-3006.
31. Jenison, S. A., X.-P. Yu, J. M. Valentine, and D. A. Galloway. 1989. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. J Virol. 63:809-818.
32. Jenison, S. A., X.-P. Yu, J. M. Valentine, and D. A. Galloway. 1991. Characterization of human antibody-reactive epitopes encoded by human papilloraavirus types 16 and 18. J. Virol 65:1208-1218
33. Kahlon, J., F. D. Lakeman, M. Ackermann, and R. J. Whitley. 1986. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin. Microbiol. 23:725-730
34. Koerner, T. J., J. E. Hill. A. M. Myers, and A. Tzagoloff. 1991. High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. Methods Enzymol. 194:477-490.
35. Kohl, S., N. C. J. Strynadka, R. S. Hodges, and L. Pereira. 1990. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B J Clin. Invest. 86:273-278.
36. Kousoulas, K., M. Arsenakis, and L. Pereira. 1989. Subset of type-specific epitopes map m the amino terminus of herpes simplex virus type 1 glycoprotein B. J Gen. Virol 70:735-741.
37. Kousoulas, K. G., B. Huo, and L. Pereira. 1988. Antibody-resistant mutations in cross-reactive and type-specific epitopes of herpes simplex virus 1 glycoprotein B map in separate domains. Virology 166:423-431.
38. Kousoulas, K. G., P. E. Pelaett, L. Pereira, and B. Roizman. 1984. Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1 (F) gB gene Virology 135:379-394
39. Langenberg, A. G. M., R. L. Burke, S. F. Adair, R. Sekulovich, M. Tigges, C. L. Dekker, and L. Corey. 1995. A recombinant glycoprotein vaccine for herpes simplex type 2: safety and efficacy. Ann. Intern. Med. 122:889-898.
40. Lee, F. K., R. M. Coleman. L. Pereira, P. D. Bailey, M. Tatsuno, and A. J. Nahmias. 1985. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G J. Clin. Microbiol. 22:641-644.
41. Lehtinen, M., V. Koivisto, T. Lehtinen, J. Paavonen, and P. Leinikki. 1985 Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology 24:18-25.
42. McClung, H., P. Seth, and W. Rawls. 1976. Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of herpes simplex virus types 1 and 2. Am J. Epidemiol. 104:192-201.
43. McDermott, M. R., F. L. Graham, T. Hanke, and D. C. Johnson. 1989. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expression HSV glycoprotein B Virology 169:3431-3437.
44. Mertz, G. J., R. Ashley, R. L. Burke, J. Benedetti, C. Critchlow, C. C. Jones, and L. Corcy. 1990. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J. Infect. Dis. 161:653-660.
45. Mester, J. C., S. L. Highlander, A. P. Osmand, J. C. Glorioso, and B. T. Rouse. 1990. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. J. Virol. 64:5277-5283.
46. Navarro, D., P. Paz, and L. Pereira. 1992 Domains of herpes simplex virus 1 glycoprotein B that function m virus penetration, cell-to-cell spread, and cell fusion. Virology 186:99-112.
47. Parkes, D. L., C. M. Smith, J. M. Rose, J. Brandis, and S. R. Coates. 1991. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J. Clin. Microbiol. 29:778-781.
48. Pellett, P. E., K. G. Kousoulas, L. Pereira, and B. Roizman. 1985. Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants, J. Virol. 53:243-253.
49. Pereira, L., M. Ali, K. Kousoulas, B. Huo, and T. Banks. 1989. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172:11-24
50. Qadri, I., C. Gimeno, D. Navarro, and L. Pereira. 1991. Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B aftect the antigenic properties, dimerization, and transport of the molecule. Virology 180:135-152.
51. Sanchez-Pescador, L., P. Paz, D. Navarro, L. Pereira, and S. Kohl. 1992. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxiaty. J. Infect Dis. 166:623-627.
52. Sanchez-Pescador, L., L. Pereira, and E. D. Charlebois. 1993. Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes denned by inhibition of murine monoclonal antibodies. J. Infect. Dis. 168:844-853.
53. Sarmiento, M., M. Haffey, and P. Spear. 1979. Membrane proteins specified by herpes simplex viruses: role of glycoprotein VP7 (B2) in virion infectivity. J. Virol. 29:1149-1158.
54. Spear, P. G. 1984. Glycoproteins specified by herpes simplex virus, p. 315-356. In B. Roizman (ed.). The herpesviruses, vol. 3. Plenum Press, New York
55. Stanberry, L. R., D. I. Bernstein, R. L. Burke, C. Pachl, and M. G. Myers. 1987, Vaccination with recombinant herpes simplex virus glycoproteins protection against initial and recurrent disease. J Infect Dis. 155:914-919.
56. Stuve, L. L., S. Brown-Shimer, C. Pachl, R. Najarian, D. Dina, and R. L. Burke. 1987. Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene J. Virol. 61:326-335.
57. Verstergaard, B. F. 1980. Herpes simplex virus antigens and antibodies a survey of studies based on quantitative immunoelectrophoresis. Rev. Infect. Dis. 2:899-913.
58. Yaegashi, N., S. A. Jenison, M. Batra, and D. A. Galloway. 1992. Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 J. Virol. 66:2008-2019.
59. Yamada, T., B. Hjelle, R. Lanzi, C. Morris, B. Anderson, and S. Jenison. 1995 Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein. J. Virol. 69:1939-1943.